The privatisation offer for this small Catalist company could cause SGX some discomfort
The proposal to take Singapore Paincare private comes a mere five years after IPO, and highlights the local bourse’s chronic lack of liquidity
Add BT as a preferred source
[SINGAPORE] Amid a flurry of delistings from the Singapore Exchange (SGX), one more privatisation offer – especially that for a small Catalist player – should not make much of a difference.
After all, the local bourse looks on pace to hit at least 20 delistings or privatisation offers in the first half of this year.
Already, firms such as offshore oil-and-gas contractor Dyna-Mac and software company Silverlake Axis have delisted this year.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
MAS convenes bank CEOs over AI cyberthreats; boards told to own risks, not leave to IT teams
Is it time to scrap COE categories for cars?
